Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Phase I trial using patupilone (epothilone B) and concurrent radiotherapy for central nervous system malignancies.

Fogh S, Machtay M, Werner-Wasik M, Curran WJ Jr, Bonanni R, Axelrod R, Andrews D, Dicker AP.

Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1009-16. doi: 10.1016/j.ijrobp.2009.06.050. Epub 2009 Oct 30.

PMID:
19879067
2.

Phase I dose-finding study of weekly single-agent patupilone in patients with advanced solid tumors.

Rubin EH, Rothermel J, Tesfaye F, Chen T, Hubert M, Ho YY, Hsu CH, Oza AM.

J Clin Oncol. 2005 Dec 20;23(36):9120-9. Epub 2005 Nov 21.

3.

A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.

Marcus KJ, Dutton SC, Barnes P, Coleman CN, Pomeroy SL, Goumnerova L, Billett AL, Kieran M, Tarbell NJ.

Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1182-5.

PMID:
12654425
4.

Phase I trial of bortezomib and concurrent external beam radiation in patients with advanced solid malignancies.

Pugh TJ, Chen C, Rabinovitch R, Eckhardt SG, Rusthoven KE, Swing R, Raben D.

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):521-6. doi: 10.1016/j.ijrobp.2009.07.1715. Epub 2010 Feb 3.

PMID:
20133082
5.

Phase I study of the novel epothilone analog ixabepilone (BMS-247550) in patients with advanced solid tumors and lymphomas.

Aghajanian C, Burris HA 3rd, Jones S, Spriggs DR, Cohen MB, Peck R, Sabbatini P, Hensley ML, Greco FA, Dupont J, O'Connor OA.

J Clin Oncol. 2007 Mar 20;25(9):1082-8. Epub 2007 Jan 29.

6.

Phase I study of hyperfractionated accelerated radiotherapy and escalating doses of daily cisplatin for patients with locally advanced non-small-cell lung cancer.

Schild SE, Wong WW, Vora SA, Halyard MY, Wheeler RH.

Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):729-34.

PMID:
12377324
7.
8.

Safety and efficacy of patupilone in patients with advanced ovarian, primary fallopian, or primary peritoneal cancer: a phase I, open-label, dose-escalation study.

Ten Bokkel Huinink WW, Sufliarsky J, Smit WM, Spanik S, Wagnerova M, Hirte HW, Kaye S, Johri AR, Oza AM.

J Clin Oncol. 2009 Jul 1;27(19):3097-103. doi: 10.1200/JCO.2008.20.4826. Epub 2009 May 18.

9.

Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.

Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL.

Gynecol Oncol. 2005 Jan;96(1):168-72.

PMID:
15589596
10.
11.

3D conformal radiotherapy and cisplatin for recurrent malignant glioma.

VanderSpek L, Fisher B, Bauman G, Macdonald D.

Can J Neurol Sci. 2008 Mar;35(1):57-64.

PMID:
18380278
12.

Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomas.

Fields EC, Damek D, Gaspar LE, Liu AK, Kavanagh BD, Waziri A, Lillehei K, Chen C.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):51-7. doi: 10.1016/j.ijrobp.2010.09.008. Epub 2010 Oct 29.

PMID:
21035955
13.

Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer.

Takeda K, Negoro S, Kudoh S, Okishio K, Masuda N, Takada M, Tanaka M, Nakajima T, Tada T, Fukuoka M.

Br J Cancer. 1999 Mar;79(9-10):1462-7.

14.

Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.

Kuhnt T, Becker A, Pigorsch S, Pelz T, Bloching M, Passmann M, Lotterer E, Hänsgen G, Dunst J.

Strahlenther Onkol. 2003 Oct;179(10):673-81.

PMID:
14566475
15.
16.

Patupilone (epothilone B) for recurrent glioblastoma: clinical outcome and translational analysis of a single-institution phase I/II trial.

Oehler C, Frei K, Rushing EJ, McSheehy PM, Weber D, Allegrini PR, Weniger D, Lütolf UM, Knuth A, Yonekawa Y, Barath K, Broggini-Tenzer A, Pruschy M, Hofer S.

Oncology. 2012;83(1):1-9. doi: 10.1159/000339152. Epub 2012 Jun 8.

PMID:
22688083
17.

A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.

Allen J, Siffert J, Donahue B, Nirenberg A, Jakacki R, Robertson P, DaRosso R, Thoron L, Rosovsky M, Pinto R.

Cancer. 1999 Sep 15;86(6):1064-9.

PMID:
10491535
18.

Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03.

Tsien C, Moughan J, Michalski JM, Gilbert MR, Purdy J, Simpson J, Kresel JJ, Curran WJ, Diaz A, Mehta MP; Radiation Therapy Oncology Group Trial 98-03.

Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):699-708. doi: 10.1016/j.ijrobp.2008.05.034. Epub 2008 Aug 23.

19.

Thoracic radiotherapy and daily vinorelbine as radiosensitizer in locally advanced non small cell lung cancer: a phase I study.

Gridelli C, Guida C, Barletta E, Gatani T, Fiore F, Barzelloni ML, Rossi A, de Bellis M, D'Aniello R, Scognamiglio F.

Lung Cancer. 2000 Aug;29(2):131-7.

PMID:
10963843
20.

Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma.

Rajkumar SV, Buckner JC, Schomberg PJ, Cascino TL, Burch PA, Dinapoli RP.

Int J Radiat Oncol Biol Phys. 1998 Jan 15;40(2):297-302.

PMID:
9457812
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk